Asset profile
Adebrelimab
Monoclonal antibody
Phase 3underway
Evidence outlook · registrational
Non-Small Cell Lung Cancer: registrational readout pending
Its supporting mid-stage evidence has not yet been graded on this platform. Registrational readout expected around 2028-10.
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
71 competitors in this universe: 10 direct rivals (same mechanism and indication), 1 same-class, 60 same-indication; 58 further along in development.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Adebrelimab: this drug | Phase 3 | Monoclonal antibody | PD-L1 | ||
| Atezolizumab | Approved | Monoclonal antibody | PD-L1 | ||
| Durvalumab | Approved | Monoclonal antibody | PD-L1 | ||
| Tecentriq Hybreza (atezolizumab And Hyaluronidase-Tqjs) | Approved | Monoclonal antibody | PD-L1 | ||
| CS1001 Monoclonal Antibody | Phase 3 | Monoclonal antibody | PD-L1 | ||
| Envafolimab | Phase 3 | Monoclonal antibody | PD-L1 | ||
| KL-A167 | Phase 3 | Monoclonal antibody | PD-L1 | ||
| PF-08046054 | Phase 3 | Antibody–drug conjugate | PD-L1 | ||
| HLX43 | Phase 2/3 | Antibody–drug conjugate | PD-L1 | ||
| 177Lu-RAD204 | Phase 1 | Radiopharmaceutical | PD-L1 | ||
| BPI-371153 | Phase 1 | Small molecule | PD-L1 | ||
| IBC-Ab002 | Phase 1 | Monoclonal antibody | PD-L1 | ||
| Afatinib (Gilotrif) | Approved | Small molecule | EGFR/HER1, HER2, HER4 | ||
| Alectinib (Alecensa) | Approved | Small molecule | ALK | ||
| Alymsys (bevacizumab-Maly) | Approved | Monoclonal antibody | VEGF-A | ||
| Amivantamab | Approved | Multispecific antibody | EGFR x c-MET |
…and 56 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Upcoming events
(164 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (28)
October 2026 (3)
Phase 3Neoadjuvant TherapyRecruiting
Est. primary completion 2026-10-15 · NCT06913777 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2026-10-31 · NCT06594874 · CT.gov ↗
What to watch
Phase 1/2Breast CancerRecruiting
Est. primary completion 2026-10-31 · NCT06222879 · CT.gov ↗
What to watch
November 2026 (5)
Phase 1/2Colorectal CancerNot yet recruiting
Est. primary completion 2026-11-01 · NCT06373133 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell CarcinomaRecruiting
Est. primary completion 2026-11-01 · NCT06885814 · CT.gov ↗
What to watch
Phase 2Adebrelimab, Hepatocellular Carcinoma, Transformation, Bevacizumab, TACERecruiting
Est. primary completion 2026-11-15 · NCT05970666 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2026-11-30 · NCT06685653 · CT.gov ↗
What to watch
December 2026 (20)
Phase 1Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2026-12 · NCT06735508 · CT.gov ↗
What to watch
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12 · NCT05482568 · CT.gov ↗
What to watch
Phase 1/2Ovarian CancerRecruiting
Est. primary completion 2026-12 · NCT06840002 · CT.gov ↗
What to watch
Phase 2Carcinoma, HepatocellularRecruiting
Est. primary completion 2026-12 · NCT06454578 · CT.gov ↗
What to watch
Phase 2Unresectable Biliary Tract CarcinomaRecruiting
Est. primary completion 2026-12 · NCT06749730 · CT.gov ↗
What to watch
Phase 2Small Cell Lung Cancer Extensive StageRecruiting
Est. primary completion 2026-12 · NCT06610734 · CT.gov ↗
What to watch
Phase 2Advanced Malignant TumourRecruiting
Est. primary completion 2026-12 · NCT06915142 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2026-12 · NCT06844474 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2026-12-01 · NCT07035392 · CT.gov ↗
What to watch
Phase 2Small Cell Lung Cancer Limited StageRecruiting
Est. primary completion 2026-12-01 · NCT06483282 · CT.gov ↗
What to watch
Phase 2Biliary Tract CarcinomaNot yet recruiting
Est. primary completion 2026-12-10 · NCT07062328 · CT.gov ↗
What to watch
Phase 1Osteosarcoma, Soft Tissue Sarcoma (STS)Not yet recruiting
Est. primary completion 2026-12-30 · NCT06699576 · CT.gov ↗
What to watch
Phase 2SCLC,Extensive StageRecruiting
Est. primary completion 2026-12-30 · NCT07141264 · CT.gov ↗
What to watch
Phase 2Biliary Tract CancerActive not recruiting
Est. primary completion 2026-12-30 · NCT06465563 · CT.gov ↗
What to watch
Phase 2TNBC - Triple-Negative Breast CancerNot yet recruiting
Est. primary completion 2026-12-31 · NCT06819319 · CT.gov ↗
What to watch
Phase 2Triple-negative Breast CancerRecruiting
Est. primary completion 2026-12-31 · NCT05076682 · CT.gov ↗
What to watch
Phase 2Gastric Adenocarcinoma, Gastro-esophageal Junction AdenocarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT06808971 · CT.gov ↗
What to watch
Phase 2Biliary Tract CancerRecruiting
Est. primary completion 2026-12-31 · NCT06620848 · CT.gov ↗
What to watch
Phase 2Head and Neck Squamous Cell CarcinomaNot yet recruiting
Est. primary completion 2026-12-31 · NCT06199271 · CT.gov ↗
What to watch
Phase 2Pancreatic Cancer Metastatic to LiverRecruiting
Est. primary completion 2026-12-31 · NCT06531278 · CT.gov ↗
What to watch
2027 (68)
January 2027 (1)
Phase 2Neuroendocrine Carcinoma of the Bladder, Bladder CancerRecruiting
Est. primary completion 2027-01-01 · NCT06091124 · CT.gov ↗
What to watch
February 2027 (3)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-02-01 · NCT07031154 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell CarcinomaRecruiting
Est. primary completion 2027-02-25 · NCT07452601 · CT.gov ↗
What to watch
Early phase / not applicableESCCNot yet recruiting
Est. primary completion 2027-02-28 · NCT07388095 · CT.gov ↗
What to watch
March 2027 (9)
Phase 1/2Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaRecruiting
Est. primary completion 2027-03 · NCT07059221 · CT.gov ↗
What to watch
Phase 2Advanced Breast CancerRecruiting
Est. primary completion 2027-03 · NCT06433609 · CT.gov ↗
What to watch
Phase 2Pancreatic CancerRecruiting
Est. primary completion 2027-03 · NCT06547736 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell CarcinomaNot yet recruiting
Est. primary completion 2027-03 · NCT06861894 · CT.gov ↗
What to watch
Phase 2Intrahepatic CholangiocarcinomaRecruiting
Est. primary completion 2027-03-01 · NCT06296563 · CT.gov ↗
What to watch
Phase 2GC/GEJCNot yet recruiting
Est. primary completion 2027-03-01 · NCT06684158 · CT.gov ↗
What to watch
Phase 2Extensive-stage Small-cell Lung CancerNot yet recruiting
Est. primary completion 2027-03-15 · NCT06306560 · CT.gov ↗
What to watch
Phase 2Unresectable Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-03-31 · NCT06360042 · CT.gov ↗
What to watch
Phase 2Resectable Intrahepatic Cholangiocarcinoma With High Risk of RecurrenceRecruiting
Est. primary completion 2027-03-31 · NCT06280508 · CT.gov ↗
What to watch
April 2027 (6)
Phase 2Intrahepatic Cholangiocarcinoma (Icc)Not yet recruiting
Est. primary completion 2027-04 · NCT06648525 · CT.gov ↗
What to watch
Phase 1/2Extensive-stage Small-cell Lung CancerNot yet recruiting
Est. primary completion 2027-04-01 · NCT06332950 · CT.gov ↗
What to watch
Phase 2Solid TumorNot yet recruiting
Est. primary completion 2027-04-01 · NCT06537505 · CT.gov ↗
What to watch
Phase 2Biliary Tract Neoplasms ImmunotherapyRecruiting
Est. primary completion 2027-04-15 · NCT07704177 · CT.gov ↗
What to watch
Phase 2Biliary Tract Neoplasms ImmunotherapyRecruiting
Est. primary completion 2027-04-29 · NCT07670273 · CT.gov ↗
What to watch
Phase 2Limited Stage Small Cell Lung CancerRecruiting
Est. primary completion 2027-04-30 · NCT06943235 · CT.gov ↗
What to watch
May 2027 (6)
Phase 2Gastric Cancer/Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2027-05-01 · NCT06385873 · CT.gov ↗
What to watch
Phase 2Biliary Tract CancerNot yet recruiting
Est. primary completion 2027-05-01 · NCT06389500 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-05-19 · NCT06424899 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell CarcinomaNot yet recruiting
Est. primary completion 2027-05-30 · NCT06508229 · CT.gov ↗
What to watch
Phase 1/2Head and Neck Squamous Cell CarcinomaRecruiting
Est. primary completion 2027-05-31 · NCT07105592 · CT.gov ↗
What to watch
Phase 1/2Advanced Urothelial CarcinomaRecruiting
Est. primary completion 2027-05-31 · NCT06639347 · CT.gov ↗
What to watch
June 2027 (12)
Phase 1/2Pancreatic CancerRecruiting
Est. primary completion 2027-06 · NCT06427239 · CT.gov ↗
What to watch
Phase 2Pancreatic CancerRecruiting
Est. primary completion 2027-06 · NCT07131514 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma Non-resectableNot yet recruiting
Est. primary completion 2027-06 · NCT07192848 · CT.gov ↗
What to watch
Phase 2Intrahepatic Cholangiocarcinoma (Icc)Recruiting
Est. primary completion 2027-06-01 · NCT06925516 · CT.gov ↗
What to watch
Phase 2HNSCCNot yet recruiting
Est. primary completion 2027-06-01 · NCT07778732 · CT.gov ↗
What to watch
Phase 2Gastroesophageal Adenocarcinoma, Gastric AdenocarcinomaRecruiting
Est. primary completion 2027-06-01 · NCT06985602 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-06-15 · NCT06480136 · CT.gov ↗
What to watch
Phase 2Biliary Tract Cancer, Biliary Tract Cancer (CCA)Recruiting
Est. primary completion 2027-06-30 · NCT07135544 · CT.gov ↗
What to watch
Phase 2Pancreatic Cancer MetastaticNot yet recruiting
Est. primary completion 2027-06-30 · NCT07230301 · CT.gov ↗
What to watch
Phase 2Biliary Tract NeoplasmsRecruiting
Est. primary completion 2027-06-30 · NCT07668453 · CT.gov ↗
What to watch
Phase 2Oral Squamous Cell Carcinoma (OSCC), Neoadjuvant ChemoimmunotherapyNot yet recruiting
Est. primary completion 2027-06-30 · NCT07137858 · CT.gov ↗
What to watch
Early phase / not applicablePathological Complete Remission, Objective Response Rate, Immune-related Adverse Events, Quality of LifeRecruiting
Est. primary completion 2027-06-30 · NCT07430579 · CT.gov ↗
What to watch
July 2027 (4)
Phase 2Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence RiskNot yet recruiting
Est. primary completion 2027-07 · NCT07682272 · CT.gov ↗
What to watch
Phase 2Small Cell Lung Cancer Extensive StageNot yet recruiting
Est. primary completion 2027-07-25 · NCT06786312 · CT.gov ↗
What to watch
Phase 2Stomach NeoplasmsRecruiting
Est. primary completion 2027-07-31 · NCT07309185 · CT.gov ↗
What to watch
Phase 2Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung CancerRecruiting
Est. primary completion 2027-07-31 · NCT06562920 · CT.gov ↗
What to watch
August 2027 (3)
Phase 3Limited Stage Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-08-01 · NCT05496166 · CT.gov ↗
What to watch
Phase 2Locally Advanced Hypopharyngeal CancerNot yet recruiting
Est. primary completion 2027-08-20 · NCT07137039 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-08-30 · NCT07778745 · CT.gov ↗
What to watch
September 2027 (2)
October 2027 (3)
Phase 1/2Locally Advanced or Metastatic Pancreatic Cancer WithRecruiting
Est. primary completion 2027-10 · NCT07296341 · CT.gov ↗
What to watch
Phase 2Pancreatic CancerNot yet recruiting
Est. primary completion 2027-10 · NCT07691593 · CT.gov ↗
What to watch
Phase 2Lung, RadiotherapyRecruiting
Est. primary completion 2027-10-30 · NCT07583550 · CT.gov ↗
What to watch
November 2027 (1)
December 2027 (18)
Phase 1/2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-12 · NCT06754930 · CT.gov ↗
What to watch
Phase 1/2Patients With Advanced or Metastatic Malignant TumorsRecruiting
Est. primary completion 2027-12 · NCT07073534 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-12 · NCT07281209 · CT.gov ↗
What to watch
Phase 2HER2 Expression Gastric Cancer/Gastroesophageal Junction AdenocarcinomaRecruiting
Est. primary completion 2027-12 · NCT05671822 · CT.gov ↗
What to watch
Phase 2Advanced Esophageal Squamous Cell CarcinomaRecruiting
Est. primary completion 2027-12 · NCT07751341 · CT.gov ↗
What to watch
Phase 2Pancreatic Cancer Non-resectable, Pancreatic Cancer MetastaticNot yet recruiting
Est. primary completion 2027-12-01 · NCT06916975 · CT.gov ↗
What to watch
Phase 2Extensive-Stage Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-12-01 · NCT06614621 · CT.gov ↗
What to watch
Early phase / not applicableHepatocellular Carcinoma(HCC)Recruiting
Est. primary completion 2027-12-15 · NCT06893887 · CT.gov ↗
What to watch
Phase 1CLDN18.2-positive Advanced Solid TumorRecruiting
Est. primary completion 2027-12-30 · NCT06350006 · CT.gov ↗
What to watch
Phase 2Pancreatic Cancer, Neoadjuvant TherapyNot yet recruiting
Est. primary completion 2027-12-30 · NCT06177522 · CT.gov ↗
What to watch
Phase 2Breast Neoplasm, Breast Cancer, Breast Tumors, Triple-Negative Breast Cancer (TNBC), HER2-positive Breast Cancer …Recruiting
Est. primary completion 2027-12-31 · NCT05582499 · CT.gov ↗
What to watch
Phase 2Neuroendocrine TumorsNot yet recruiting
Est. primary completion 2027-12-31 · NCT06764368 · CT.gov ↗
What to watch
Phase 2Rare TumourNot yet recruiting
Est. primary completion 2027-12-31 · NCT06692491 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal CancerRecruiting
Est. primary completion 2027-12-31 · NCT07718490 · CT.gov ↗
What to watch
Phase 2Esophageal Cancer (EsC)Recruiting
Est. primary completion 2027-12-31 · NCT06869213 · CT.gov ↗
What to watch
Phase 2Esophageal CancerRecruiting
Est. primary completion 2027-12-31 · NCT07733830 · CT.gov ↗
What to watch
Phase 2ESCCNot yet recruiting
Est. primary completion 2027-12-31 · NCT07584031 · CT.gov ↗
What to watch
2028 (44)
January 2028 (6)
Phase 2Esophageal Squamous Cell Carcinoma (ESCC)Recruiting
Est. primary completion 2028-01-01 · NCT07638436 · CT.gov ↗
What to watch
Phase 2Cholangiocarcinoma, Biliary Tract CancerNot yet recruiting
Est. primary completion 2028-01-01 · NCT07561775 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell Carcinoma (ESCC)Recruiting
Est. primary completion 2028-01-01 · NCT07595770 · CT.gov ↗
What to watch
Phase 2HER2-negative Breast CancerNot yet recruiting
Est. primary completion 2028-01-15 · NCT07466927 · CT.gov ↗
What to watch
Phase 1/2Advanced Biliary Tract CarcinomaRecruiting
Est. primary completion 2028-01-30 · NCT07392541 · CT.gov ↗
What to watch
Phase 3Locally Advanced or Metastatic Urothelial CarcinomaRecruiting
Est. primary completion 2028-01-31 · NCT07393542 · CT.gov ↗
What to watch
February 2028 (4)
Phase 2Cervical CancerNot yet recruiting
Est. primary completion 2028-02 · NCT06149767 · CT.gov ↗
What to watch
Phase 2Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-02-01 · NCT07398560 · CT.gov ↗
What to watch
Phase 2Adebrelimab, Adenocarcinoma of GE Junction, Adenocarcinoma of StomachRecruiting
Est. primary completion 2028-02-01 · NCT07353684 · CT.gov ↗
What to watch
Phase 2/3Ovarian Cancer RecurrentRecruiting
Est. primary completion 2028-02-14 · NCT06791460 · CT.gov ↗
What to watch
March 2028 (5)
Phase 3PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast CancerRecruiting
Est. primary completion 2028-03 · NCT07111832 · CT.gov ↗
What to watch
Phase 2Locally Advanced or Metastatic Esophageal Squamous Cell CarcinomaRecruiting
Est. primary completion 2028-03-01 · NCT06339619 · CT.gov ↗
What to watch
Phase 2Thymic CarcinomaNot yet recruiting
Est. primary completion 2028-03-01 · NCT07479628 · CT.gov ↗
What to watch
Phase 2Limited-stage Small-cell Lung Cancer, Concurrent Chemoradiation TherapyNot yet recruiting
Est. primary completion 2028-03-30 · NCT07200154 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-03-30 · NCT07824882 · CT.gov ↗
What to watch
April 2028 (1)
Phase 3Advanced Cervical CancerRecruiting
Est. primary completion 2028-04 · NCT07168200 · CT.gov ↗
What to watch
May 2028 (3)
Phase 2Nasopharyngeal Carcinoma, Nasopharyngeal CancerRecruiting
Est. primary completion 2028-05-01 · NCT06349889 · CT.gov ↗
What to watch
Phase 2Head and Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruiting
Est. primary completion 2028-05-01 · NCT07554768 · CT.gov ↗
What to watch
Phase 2Rectal Cancer PatientsActive not recruiting
Est. primary completion 2028-05-29 · NCT07687433 · CT.gov ↗
What to watch
June 2028 (4)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-06 · NCT07704645 · CT.gov ↗
What to watch
Phase 2HER2-positive Locally Advanced or Metastatic Biliary Tract CancerRecruiting
Est. primary completion 2028-06 · NCT06778031 · CT.gov ↗
What to watch
Phase 2TNBC, Triple Negative Breast Cancer, Brain MetastasasesRecruiting
Est. primary completion 2028-06-30 · NCT07638852 · CT.gov ↗
What to watch
Phase 2Advanced Hepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2028-06-30 · NCT06737913 · CT.gov ↗
What to watch
July 2028 (2)
August 2028 (7)
Phase 1/2Pancreatic Ductal Adenocarcinoma (PDAC), Locally Advanced and Metastatic Pancreatic CancerRecruiting
Est. primary completion 2028-08 · NCT07595172 · CT.gov ↗
What to watch
Phase 2Localized Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-08 · NCT07381543 · CT.gov ↗
What to watch
Phase 2Cervical NeoplasmsRecruiting
Est. primary completion 2028-08-01 · NCT07731828 · CT.gov ↗
What to watch
Phase 2Esophageal CancerNot yet recruiting
Est. primary completion 2028-08-01 · NCT07780721 · CT.gov ↗
What to watch
Phase 2Limited-stage Small Cell Lung Cancer (LS-SCLC)Enrolling by invitation
Est. primary completion 2028-08-01 · NCT06773156 · CT.gov ↗
What to watch
Phase 1/2Pancreatic Cancer, RAS Mutations or AmplificationsNot yet recruiting
Est. primary completion 2028-08-30 · NCT07736612 · CT.gov ↗
What to watch
Phase 2Head and Neck Cancer Squamous Cell CarcinomaRecruiting
Est. primary completion 2028-08-30 · NCT07457346 · CT.gov ↗
What to watch
September 2028 (3)
Phase 2Brain Metastasis From Advanced HER2-negative Breast CancerRecruiting
Est. primary completion 2028-09-10 · NCT06839560 · CT.gov ↗
What to watch
Phase 2Advanced Triple-negative Breast CancerRecruiting
Est. primary completion 2028-09-10 · NCT06771609 · CT.gov ↗
What to watch
Phase 2Small Cell Lung CarcinomaNot yet recruiting
Est. primary completion 2028-09-26 · NCT07357532 · CT.gov ↗
What to watch
October 2028 (2)
Phase 2/3Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-10 · NCT06335355 · CT.gov ↗
What to watch
Phase 2Breast Cancer Early Stage Breast Cancer (Stage 1-3), HR Positive/HER2 Low Breast CancerNot yet recruiting
Est. primary completion 2028-10-15 · NCT07317778 · CT.gov ↗
What to watch
November 2028 (1)
Phase 2Rectal Cancer, Advanced Stage Colorectal Cancer, RadiotherapyRecruiting
Est. primary completion 2028-11-30 · NCT07284992 · CT.gov ↗
What to watch
December 2028 (6)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-12 · NCT07567326 · CT.gov ↗
What to watch
Phase 2Breast CancerNot yet recruiting
Est. primary completion 2028-12 · NCT06842472 · CT.gov ↗
What to watch
Phase 2Malignant Solid TumorsRecruiting
Est. primary completion 2028-12 · NCT07268040 · CT.gov ↗
What to watch
Phase 2Malignant Solid TumorsRecruiting
Est. primary completion 2028-12 · NCT07028281 · CT.gov ↗
What to watch
Phase 2Biliary Tract CancerRecruiting
Est. primary completion 2028-12-30 · NCT07569679 · CT.gov ↗
What to watch
Phase 1Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-12-31 · NCT06963502 · CT.gov ↗
What to watch
2029 (11)
February 2029 (1)
Phase 1Biliary Tract MalignanciesRecruiting
Est. primary completion 2029-02-23 · NCT06181032 · CT.gov ↗
What to watch
April 2029 (1)
Phase 2Recurrent/Metastatic Endometrial CancerNot yet recruiting
Est. primary completion 2029-04-01 · NCT06771154 · CT.gov ↗
What to watch
June 2029 (2)
July 2029 (1)
Phase 2SCLC, Limited StageRecruiting
Est. primary completion 2029-07-17 · NCT07559786 · CT.gov ↗
What to watch
August 2029 (2)
Phase 2Gastric Cancer, HER2 + Gastric Cancer, CLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction, PD-L1 PositiveNot yet recruiting
Est. primary completion 2029-08-01 · NCT06881017 · CT.gov ↗
What to watch
Phase 2Adebrelimab (SHR-1316), Bevacizumab, Hepatocellular Carcinoma (HCC)Not yet recruiting
Est. primary completion 2029-08-31 · NCT07543783 · CT.gov ↗
What to watch
December 2029 (4)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2029-12 · NCT07836543 · CT.gov ↗
What to watch
Phase 3Advanced Biliary Tract CancerRecruiting
Est. primary completion 2029-12 · NCT07229625 · CT.gov ↗
What to watch
Phase 3Locally Advanced Gastric or Gastroesophageal Junction CancerRecruiting
Est. primary completion 2029-12 · NCT07522151 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal Cancinoma (NPC), Nasopharangeal CancerNot yet recruiting
Est. primary completion 2029-12-01 · NCT07238569 · CT.gov ↗
What to watch
2030 (7)
May 2030 (2)
June 2030 (1)
Phase 2Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma, Mismatch Repair Deficient or MSI-High Solid Tumors, ImmunotherapyNot yet recruiting
Est. primary completion 2030-06-30 · NCT07266025 · CT.gov ↗
What to watch
July 2030 (1)
Phase 2Liver Cancer (Primary and Metastatic)Not yet recruiting
Est. primary completion 2030-07-01 · NCT07684040 · CT.gov ↗
What to watch
October 2030 (1)
Phase 3Patients With Unresectable Locally Advanced or Metastatic Untreated Gastric or Gastroesophageal Junction AdenocarcinomaRecruiting
Est. primary completion 2030-10 · NCT07118527 · CT.gov ↗
What to watch
2031 (5)
April 2031 (1)
Phase 3Hepatocellular CarcinomaNot yet recruiting
Est. primary completion 2031-04 · NCT07691762 · CT.gov ↗
What to watch
May 2031 (1)
Phase 2/3Esophageal Squamous Cell Carcinoma (ESCC)Not yet recruiting
Est. primary completion 2031-05 · NCT06861777 · CT.gov ↗
What to watch
October 2031 (1)
Phase 2Colorectal CancerActive not recruiting
Est. primary completion 2031-10 · NCT07071714 · CT.gov ↗
What to watch
2032 (1)
November 2032 (1)
Phase 2/3Locally Advanced Resectable Rectal CancerRecruiting
Est. primary completion 2032-11 · NCT07454720 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.